Co-Authors
This is a "connection" page, showing publications co-authored by Omnia Kutkat and Rabeh El-Shesheny.
Connection Strength
0.549
-
Bioactive Polyphenolic Compounds Showing Strong Antiviral Activities against Severe Acute Respiratory Syndrome Coronavirus 2. Pathogens. 2021 Jun 15; 10(6).
Score: 0.059
-
Incidence, household transmission, and neutralizing antibody seroprevalence of Coronavirus Disease 2019 in Egypt: Results of a community-based cohort. PLoS Pathog. 2021 03; 17(3):e1009413.
Score: 0.058
-
Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies. Vaccines (Basel). 2021 Mar 03; 9(3).
Score: 0.058
-
FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2. Pharmaceuticals (Basel). 2020 Dec 04; 13(12).
Score: 0.057
-
Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibodies in Egyptian Convalescent Plasma Donors. Front Microbiol. 2020; 11:596851.
Score: 0.057
-
Common childhood vaccines do not elicit a cross-reactive antibody response against SARS-CoV-2. PLoS One. 2020; 15(10):e0241471.
Score: 0.057
-
Coding-Complete Genome Sequences of Two SARS-CoV-2 Isolates from Egypt. Microbiol Resour Announc. 2020 May 28; 9(22).
Score: 0.055
-
Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East. Viruses. 2019 08 05; 11(8).
Score: 0.052
-
Middle East respiratory syndrome coronavirus infection in non-camelid domestic mammals. Emerg Microbes Infect. 2019; 8(1):103-108.
Score: 0.050
-
Systematic, active surveillance for Middle East respiratory syndrome coronavirus in camels in Egypt. Emerg Microbes Infect. 2017 Jan 04; 6(1):e1.
Score: 0.044